Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID04934462

Prospective Evaluation of Non-Surgical and Arthroscopic Treatment for Hip Microinstability

Led by Göteborg University · Updated on 2025-03-12

26

Participants Needed

3

Research Sites

N/A

Total Duration

On this page

Sponsors

G

Göteborg University

Lead Sponsor

T

The Swedish Society of Medicine

Collaborating Sponsor

AI-Summary

What this Trial Is About

Hip microinstability causes pain and reduced function in young, active people due to unusual hip movement. This condition may be linked to factors like acetabular dysplasia, connective tissue disorders, trauma, or unknown causes. Researchers are studying how non-surgical and surgical treatments affect hip function and side effects in people with this condition. Participants first undergo six months of physiotherapy focused on stabilizing the hip joint. If this non-surgical approach does not improve symptoms, they will have a diagnostic hip arthroscopy. If microinstability is confirmed during surgery, an arthroscopic plication of the hip joint capsule is performed. The study tracks changes after both types of treatment. Throughout the study, participants complete patient-reported outcome scores, strength, and function tests at the start and at 6, 12, and 24 months after treatment. Researchers measure hip function using tools like iHOT-12 and HAGOS, along with muscle strength and hop performance. They also evaluate quality of life, sports activity level, satisfaction with treatment, and any adverse events over two years.

CONDITIONS

Brief Title

Evaluation of Non-Surgical and Arthroscopic Treatment for Hip Microinstability

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Hip microinstability
  • Minimum 18 years old
Not Eligible

You will not qualify if you...

  • Hip osteoarthritis
  • Severe hip dysplasia
  • Perthes disease or avascular necrosis of the femoral head
  • Previous surgery to the hip joint

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Non-Surgical Treatment

Duration - 6 months

Participants undergo six months of physiotherapy aimed at stabilizing the hip joint.

Visits as part of physiotherapy over 6 months

Surgical Treatment

Duration - Up to 1 month

Participants who do not improve with physiotherapy undergo arthroscopic plication of the hip joint capsule.

1 surgical procedure and approximately 6 post-operative visits

Follow-up Evaluations

Duration - Up to 24 months post-treatment

Participants are evaluated with patient-reported outcome scores and strength and function tests at multiple time points after treatment.

Visits at 6, 12, and 24 months following treatment

Trial Site Locations

Total: 3 locations

1

GHP Ortho Center Göteborg

Gothenburg, Sweden, 41346

Not Yet Recruiting

2

University of Gothenburg

Gothenburg, Sweden, 41676

Actively Recruiting

3

Capio Artro Clinic

Stockholm, Sweden, 11428

Not Yet Recruiting

Loading map...

Research Team

A

Axel Öhlin, MD, PhD

M

Mikael Sansone, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Advanced Surgical Simulation Processes in the Correction of ...

Musculoskeletal Deformity

Actively Recruiting

7 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Protocol for a multicenter prospective cohort study evaluating arthroscopic and non-surgical treatment for microinstability of the hip joint.

Axel Öhlin, Eric Hamrin Senorski, Mikael Sansone...

https://pubmed.ncbi.nlm.nih.gov/35361185